(PRWEB) January 22, 2014
Protectus Medical Devices was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Marina Del Rey, California.
Protectus Medical Devices, Inc., a public, development-stage company, is engaged in the design, engineering, and manufacture of safety needle devices to protect healthcare workers worldwide from millions of accidental needle stick injuries annually, as well as to obviate billions of dollars in resulting healthcare costs every year. The Company primarily offers the patented-protected, automatic, self-sheathing Protectus Safety Syringe, a safety hypodermic syringe that is intended for general use. The device has received 510(K) permission from the US FDA to be marketed and sold in the US.
During the interview Protectus Medical Devices President & CEO, John Salstrom, said, "Needle stick injuries are a very frequent event in the United States, actually all over the world. Of the 8 billion syringes sold in the US every year, approximately 1 and a half million end up causing needle stick injuries."
Mr.Salstrom added, "If the needle has been in a patient that has some blood born disease and therefore is contaminated with fluids from that patient; and you then inject yourself by accident or somebody else injects themselves by accident, they could contract that disease. And, in fact, that happens tens of thousand of times per year and results in hundreds of deaths each year."
The needle stick injury problem is huge in the United States. Although there are federal and state laws requiring safety syringes be used, all of the devices that are out there require the user to intentionally perform a manual action to deploy the safety feature. The Protectus Medical Devices safety needle device is automatic. When the user gives an injection, a sheath snaps down over the needle and renders the device safe.
The interview was conducted by FSXinterlinked Investment Conference Host, Michael Fugler, and is available on the FSXinterlinked channel on InterlinkedTV. More information is available at Protectus Medical Devices' Public Profile on Interlinked.com.
About FSXinterlinked Investment Conference
FSXinterlinked is the premier investment conference organization in the United States. Founded as Financial Services Exchange (FSX) in 1983, it is a national organization comprised of independent FINRA broker/dealer firms and private equity fund managers. With quarterly investment conferences hosted throughout the U.S., FSXinterlinked creates a forum for emerging growth companies seeking capital to present to a nationwide network of financial investment professionals.
The FSXinterlinked network of independent broker/dealers has a combined sales force of thousands of accredited investors looking to invest in companies of all sizes and industries. To date, more than $3 billion has been raised for presenting companies through the FSXinterlinked network. FSXinterlinked’s exclusive network of FINRA firms makes the investment conferences the ideal setting for private and public companies seeking mezzanine financing, funding for private placements, IPOs, secondary financing and pipes, exposure, and more. For more information, visit http://www.fsxinterlinked.com/.
Interlinked is a global investment community of accredited investors, emerging growth companies, and resource partners. Interlinked offers an efficient way for companies to maximize exposure and access a private network of funding sources and verified service providers. For investors, Interlinked provides a secure environment to find, vet and engage companies, and communicate with members. Interlinked gives members exclusive access to a proprietary investment platform, which integrates virtual data rooms, video news, a service provider marketplace, an event directory, and customized marketing services, including email marketing, video production, public relations and more. For more information, visit: http://www.interlinked.com/.
Safe Harbor Statement
This press release may contain information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release, including words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.